D. Horrobin, A. Glen, and K. Vaddadi, The membrane hypothesis of schizophrenia, Schizophrenia Research, vol.13, issue.3, pp.195-207, 1994.
DOI : 10.1016/0920-9964(94)90043-4

J. Holthuis and T. Levine, Lipid traffic: floppy drives and a superhighway, Nature Reviews Molecular Cell Biology, vol.9, issue.3, pp.209-220, 2005.
DOI : 10.1038/nrm1591

P. Devaux and R. Morris, Transmembrane Asymmetry and Lateral Domains in Biological Membranes, Traffic, vol.277, issue.4, pp.241-246, 2004.
DOI : 10.1111/j.1600-0854.2004.0170.x

G. Meer, D. Voelker, and G. Feigenson, Membrane lipids: where they are and how they behave, Nature Reviews Molecular Cell Biology, vol.18, issue.2, pp.112-124, 2008.
DOI : 10.1038/nrm2330

M. Soderberg, C. Edlund, K. Kristensson, and G. Dallner, Lipid Compositions of Different Regions of the Human Brain During Aging, Journal of Neurochemistry, vol.27, issue.2, pp.415-423, 1990.
DOI : 10.1016/S0140-6736(82)91717-2

J. Yao, J. Stanley, R. Reddy, M. Keshavan, and J. Pettegrew, Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites, Biological Psychiatry, vol.52, issue.8, pp.823-830, 2002.
DOI : 10.1016/S0006-3223(02)01397-5

B. Peters, M. Machielsen, W. Hoen, M. Caan, A. Malhotra et al., Polyunsaturated Fatty Acid Concentration Predicts Myelin Integrity in Early-Phase Psychosis, Schizophrenia Bulletin, vol.39, issue.4, pp.830-838, 2013.
DOI : 10.1093/schbul/sbs089

A. Richardson, S. Allen, J. Hajnal, I. Cox, T. Easton et al., Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.25, issue.8, pp.1513-1521, 2001.
DOI : 10.1016/S0278-5846(01)00211-1

A. Ponizovsky, I. Modai, Y. Nechamkin, G. Barshtein, M. Ritsner et al., Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatology, Schizophrenia Research, vol.52, issue.1-2, pp.121-126, 2001.
DOI : 10.1016/S0920-9964(00)00189-4

A. Schmitt, A. Maras, G. Petroianu, D. Braus, L. Scheuer et al., Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia, Journal of Neural Transmission, vol.108, issue.8-9, pp.1081-1091, 2001.
DOI : 10.1007/s007020170026

J. Jensen, J. Miller, P. Williamson, R. Neufeld, R. Menon et al., Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla, Psychiatry Research: Neuroimaging, vol.146, issue.2, pp.127-135, 2006.
DOI : 10.1016/j.pscychresns.2005.11.004

P. Tessier, C. Ferreri, F. , D. Hert, M. Peuskens et al., Abnormal transbilayer distribution of phospholipids in red blood cell membranes in schizophrenia, Psychiatry Res, vol.169, pp.91-96, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00416470

W. Hoen, J. Lijmer, M. Duran, R. Wanders, N. Van-beveren et al., Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: A meta-analysis, Psychiatry Research, vol.207, issue.1-2, pp.1-12, 2013.
DOI : 10.1016/j.psychres.2012.09.041

K. Ohara, The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.31, issue.2, pp.469-474, 2007.
DOI : 10.1016/j.pnpbp.2006.11.013

D. Garner and . Edi-, Eating Disorder Inventory-2. Psychological Assessment Resources, 1991.

S. Kay, A. Fiszbein, and L. Opler, The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia, Schizophrenia Bulletin, vol.13, issue.2, pp.261-276, 1987.
DOI : 10.1093/schbul/13.2.261

J. Lee and S. Park, The role of stimulus salience in CPT-AX performance of schizophrenia patients, Schizophrenia Research, vol.81, issue.2-3, pp.191-197, 2006.
DOI : 10.1016/j.schres.2005.08.015

H. Irtel and . Pxlab, Available from o http, 2007.

J. Roiser, K. Stephan, H. Den-ouden, T. Barnes, K. Friston et al., Do patients with schizophrenia exhibit aberrant salience?, Psychological Medicine, vol.20, issue.02, pp.199-209, 2009.
DOI : 10.1037/h0048262

H. Nelson, A Modified Card Sorting Test Sensitive to Frontal Lobe Defects, Cortex, vol.12, issue.4, pp.313-324, 1976.
DOI : 10.1016/S0010-9452(76)80035-4

J. Folch, M. Lees, S. Stanley, and G. , A simple method for the isolation and purification of total lipides from animal tissues, J Biol Chem, vol.226, pp.497-509, 1957.

B. Brugger, Lipidomics: Analysis of the Lipid Composition of Cells and Subcellular Organelles by Electrospray Ionization Mass Spectrometry, Annual Review of Biochemistry, vol.83, issue.1, pp.79-98, 2014.
DOI : 10.1146/annurev-biochem-060713-035324

P. Haimi, A. Uphoff, M. Hermansson, and P. Somerharju, Software Tools for Analysis of Mass Spectrometric Lipidome Data, Analytical Chemistry, vol.78, issue.24, pp.8324-8331, 2006.
DOI : 10.1021/ac061390w

C. Fraley and A. Raftery, Bayesian Regularization for Normal Mixture Estimation and Model-Based Clustering, Journal of Classification, vol.24, issue.2, pp.155-181, 2007.
DOI : 10.1007/s00357-007-0004-5

V. Danivas and G. Venkatasubramanian, Current perspectives on chlorpromazine equivalents: comparing apples and oranges!, Indian J Psychiatry, vol.55, pp.207-208, 2013.

R. Emsley, J. Rabinowitz, M. Torreman, and G. , The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis, Schizophrenia Research, vol.61, issue.1, pp.47-57, 2003.
DOI : 10.1016/S0920-9964(02)00302-X

J. Yao, S. Leonard, and R. Reddy, Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients, Schizophrenia Research, vol.42, issue.1, pp.7-17, 2000.
DOI : 10.1016/S0920-9964(99)00095-X

A. Schmitt, K. Wilczek, K. Blennow, A. Maras, A. Jatzko et al., Altered thalamic membrane phospholipids in schizophrenia: a postmortem study, Biological Psychiatry, vol.56, issue.1, pp.41-45, 2004.
DOI : 10.1016/j.biopsych.2004.03.019

K. Davis, D. Stewart, J. Friedman, M. Buchsbaum, P. Harvey et al., White Matter Changes in Schizophrenia, Archives of General Psychiatry, vol.60, issue.5, pp.443-456, 2003.
DOI : 10.1001/archpsyc.60.5.443

S. Flynn, D. Lang, A. Mackay, V. Goghari, I. Vavasour et al., Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins, Molecular Psychiatry, vol.8, issue.9, pp.811-820, 2003.
DOI : 10.1038/sj.mp.4001337

D. Milhas, C. Clarke, and Y. Hannun, Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipids, FEBS Letters, vol.28, issue.9, pp.1887-1894, 2010.
DOI : 10.1016/j.febslet.2009.10.058

D. Lingwood and K. Simons, Lipid Rafts As a Membrane-Organizing Principle, Science, vol.327, issue.5961, pp.46-50, 2010.
DOI : 10.1126/science.1174621

K. Jacobson, O. Mouritsen, and R. Anderson, Lipid rafts: at a crossroad between cell biology and physics, Nature Cell Biology, vol.95, issue.1, pp.7-14, 2007.
DOI : 10.1038/ncb0107-7

C. Clinical, R. Measures-in-schizophrenia-georgieva, K. Mircheva, V. Vitkova, K. Balashev et al., Phospholipase A2-induced remodeling processes on liquid-ordered/liquid-disordered membranes containing docosahexaenoic or oleic acid: a comparison study, Langmuir, vol.32, pp.1756-1770, 2016.

H. Bentsen, D. Solberg, H. Refsum, J. Gran, T. Bohmer et al., Bimodal Distribution of Polyunsaturated Fatty Acids in Schizophrenia Suggests Two Endophenotypes of the Disorder, Biological Psychiatry, vol.70, issue.1, pp.97-105, 2011.
DOI : 10.1016/j.biopsych.2011.02.011

R. Bazinet and S. Laye, Polyunsaturated fatty acids and their metabolites in brain function and disease, Nature Reviews Neuroscience, vol.55, issue.12, pp.771-785, 2014.
DOI : 10.1038/nrn3820

P. Wood, G. Unfried, W. Whitehead, A. Phillipps, and J. Wood, Dysfunctional plasmalogen dynamics in the plasma and platelets of patients with schizophrenia, Schizophrenia Research, vol.161, issue.2-3, pp.506-510, 2014.
DOI : 10.1016/j.schres.2014.11.032

R. Kaddurah-daouk, J. Mcevoy, R. Baillie, H. Zhu, K. J. Nimgaonkar et al., Impaired plasmalogens in patients with schizophrenia, Psychiatry Research, vol.198, issue.3, pp.347-352, 2012.
DOI : 10.1016/j.psychres.2012.02.019

F. Dorninger, A. Brodde, N. Braverman, A. Moser, W. Just et al., Homeostasis of phospholipids ??? The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1851, issue.2, pp.117-128, 2014.
DOI : 10.1016/j.bbalip.2014.11.005

E. Thomas, R. George, P. Danielson, P. Nelson, A. Warren et al., Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins, Molecular Psychiatry, vol.8, issue.12, pp.983-993, 2003.
DOI : 10.1038/sj.mp.4001425

J. Mcevoy, R. Baillie, H. Zhu, P. Buckley, M. Keshavan et al., Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics, PLoS ONE, vol.67, issue.7, p.68717, 2013.
DOI : 10.1371/journal.pone.0068717.s001

H. Fukuzako, T. Fukuzako, S. Kodama, T. Hashiguchi, M. Takigawa et al., Haloperidol Improves Membrane Phospholipid Abnormalities in Temporal Lobes of Schizophrenic Patients, Neuropsychopharmacology, vol.21, issue.4, pp.542-549, 1999.
DOI : 10.1016/S0893-133X(99)00050-0

I. Alves, G. Staneva, C. Tessier, G. Salgado, and P. Nuss, The interaction of antipsychotic drugs with lipids and subsequent lipid reorganization investigated using biophysical methods, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1808, issue.8, pp.2009-2018, 2011.
DOI : 10.1016/j.bbamem.2011.02.021

URL : https://hal.archives-ouvertes.fr/hal-00632160

D. Solberg, H. Bentsen, H. Refsum, and O. Andreassen, Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia, Acta Psychiatrica Scandinavica, vol.12, issue.Suppl, pp.293-300, 2015.
DOI : 10.1111/acps.12388

A. Glen, E. Horrobin, D. Vaddadi, K. Spellman, M. Morse-fisher et al., A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases, Schizophrenia Research, vol.12, issue.1, pp.53-61, 1994.
DOI : 10.1016/0920-9964(94)90084-1

M. Sethom, S. Fares, N. Bouaziz, W. Melki, R. Jemaa et al., Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.83, issue.3, pp.131-136, 2010.
DOI : 10.1016/j.plefa.2010.07.001

S. Kim, M. Schafer, C. Klier, M. Berk, S. Rice et al., Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis, Schizophrenia Research, vol.158, issue.1-3, pp.39-44, 2014.
DOI : 10.1016/j.schres.2014.06.032

R. Reddy, S. Fleet-michaliszyn, R. Condray, J. Yao, M. Keshavan et al., Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary study, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.84, issue.3-4, pp.79-83, 2011.
DOI : 10.1016/j.plefa.2010.12.001

L. Zimmer, S. Vancassel, S. Cantagrel, P. Breton, S. Delamanche et al., The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids, Am J Clin Nutr, vol.75, pp.662-667, 2002.

S. Chalon, Omega-3 fatty acids and monoamine neurotransmission, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.75, issue.4-5, pp.259-269, 2006.
DOI : 10.1016/j.plefa.2006.07.005

K. Berridge, The debate over dopamine???s role in reward: the case for incentive salience, Psychopharmacology, vol.98, issue.2, pp.391-431, 2007.
DOI : 10.1007/s00213-006-0578-x

R. Smieskova, J. Roiser, C. Chaddock, A. Schmidt, F. Harrisberger et al., Modulation of motivational salience processing during the early stages of psychosis, Schizophrenia Research, vol.166, issue.1-3, pp.17-23, 2015.
DOI : 10.1016/j.schres.2015.04.036

A. Macdonald and C. Carter, Event-Related fMRI Study of Context Processing in Dorsolateral Prefrontal Cortex of Patients With Schizophrenia., Journal of Abnormal Psychology, vol.112, issue.4, pp.689-697, 2003.
DOI : 10.1037/0021-843X.112.4.689

D. 54-servan-schreiber, J. Cohen, and S. Steingard, Schizophrenic Deficits in the Processing of Context, Archives of General Psychiatry, vol.53, issue.12, pp.1105-1112, 1996.
DOI : 10.1001/archpsyc.1996.01830120037008

M. Laruelle, A. Abi-dargham, C. Van-dyck, R. Gil, D. Souza et al., Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects., Proceedings of the National Academy of Sciences, vol.93, issue.17, pp.9235-9240, 1996.
DOI : 10.1073/pnas.93.17.9235

J. Krystal, E. Perry, . Jr, R. Gueorguieva, A. Belger et al., Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and Amphetamine, Archives of General Psychiatry, vol.62, issue.9, pp.985-994, 2005.
DOI : 10.1001/archpsyc.62.9.985

O. Howes and S. Kapur, The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway, Schizophrenia Bulletin, vol.35, issue.3, pp.549-562, 2009.
DOI : 10.1093/schbul/sbp006

O. Howes and R. Murray, Schizophrenia: an integrated sociodevelopmental-cognitive model, The Lancet, vol.383, issue.9929, pp.1677-1687, 2014.
DOI : 10.1016/S0140-6736(13)62036-X

L. Zimmer, S. Delpal, D. Guilloteau, J. Aioun, G. Durand et al., Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex, Neuroscience Letters, vol.284, issue.1-2, pp.25-28, 2000.
DOI : 10.1016/S0304-3940(00)00950-2

Y. Kumakura, P. Cumming, I. Vernaleken, H. Buchholz, T. Siessmeier et al., Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study, Journal of Neuroscience, vol.27, issue.30, pp.8080-8087, 2007.
DOI : 10.1523/JNEUROSCI.0805-07.2007

O. Howes, J. Kambeitz, E. Kim, D. Stahl, M. Slifstein et al., The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment, Archives of General Psychiatry, vol.69, issue.8, pp.776-786, 2012.
DOI : 10.1001/archgenpsychiatry.2012.169

G. Lyon, A. Abi-dargham, H. Moore, J. Lieberman, J. Javitch et al., Presynaptic Regulation of Dopamine Transmission in Schizophrenia, Schizophrenia Bulletin, vol.37, issue.1, pp.108-117, 2011.
DOI : 10.1093/schbul/sbp010

W. Van-der-kemp, D. Klomp, R. Kahn, and P. Luijten, A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia, Schizophrenia Research, vol.141, issue.2-3, pp.153-161, 2012.
DOI : 10.1016/j.schres.2012.08.014

R. Mcnamara, R. Jandacek, T. Rider, P. Tso, C. Hahn et al., Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: Gender differences and partial normalization with antipsychotic medications, Schizophrenia Research, vol.91, issue.1-3, pp.37-50, 2007.
DOI : 10.1016/j.schres.2006.11.027

I. License, The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, p.2016